InsidersTradesSigma
Track the IRLAB Therapeutics AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, IRLAB Therapeutics AB has logged 0 public disclosures. Market capitalisation: €111.8m. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
IRLAB Therapeutics AB is a Swedish biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the Stockholm Stock Exchange (XSTO).